Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor.
Constitutively active JAK2V617F and thrombopoietin receptor (TpoR) W515L/K mutants are major determinants of human myeloproliferative neoplasms (MPNs). We show that a TpoRW515 mutation (W515A), which we detected in 2 myelofibrosis patients, and the Delta5TpoR active mutant, where the juxtamembrane R/KW(515)QFP motif is deleted, induce a myeloproliferative phenotype in mouse bone marrow reconstitution experiments. This phenotype required cytosolic Y112 of the TpoR. Phosphotyrosine immunoprofiling detected phosphorylated cytosolic TpoR Y78 and Y112 in cells expressing TpoRW515A. Mutation of cytosolic Y112 to phenylalanine prevented establishment of the in vivo phenotype and decreased constitutive active signaling by Delta5TpoR and TpoRW515A, especially via the mitogen-activated protein (MAP)-kinase pathway, without decreasing Janus kinase 2 (JAK2) activation. In contrast, mutation of cytosolic Y78 to phenylalanine enhanced the myeloproliferative syndrome induced by the TpoRW515 mutants, by enhancing receptor-induced JAK2 activation. We propose that TpoR cytosolic phosphorylated Y112 and flanking sequences could become targets for pharmacologic inhibition in MPNs.
Pecquet
Christian
C
Ludwig Institute for Cancer Research, Brussels, Belgium.
Staerk
Judith
J
Chaligné
Ronan
R
Goss
Valerie
V
Lee
Kimberly A
KA
Zhang
Xiaowu
X
Rush
John
J
Van Hees
Joanne
J
Poirel
Hélène A
HA
Scheiff
Jean-Marie
JM
Vainchenker
William
W
Giraudier
Stéphane
S
Polakiewicz
Roberto D
RD
Constantinescu
Stefan N
SN
D000818:Animals; D001854:Bone Marrow Cells / Q000166:cytology / Q000378:metabolism; D016026:Bone Marrow Transplantation; D002460:Cell Line; D049109:Cell Proliferation; D006801:Humans; D015151:Immunoblotting; D053614:Janus Kinase 2 / Q000378:metabolism; D051379:Mice; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D010750:Phosphoproteins / Q000378:metabolism; D010766:Phosphorylation; D054448:Precursor Cells, B-Lymphoid / Q000166:cytology / Q000378:metabolism; D055728:Primary Myelofibrosis / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D053628:Receptors, Thrombopoietin / Q000235:genetics* / Q000378:metabolism; D014162:Transfection; D014443:Tyrosine / Q000235:genetics* / Q000378:metabolism
D010750:Phosphoproteins; D053628:Receptors, Thrombopoietin; D014443:Tyrosine; D053614:Janus Kinase 2